本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioNTech SE

96.69
-2.1700-2.20%
盤後96.690.00000.00%17:53 EDT
成交量:59.04萬
成交額:5,707.87萬
市值:242.89億
市盈率:-12.44
高:97.66
開:97.04
低:95.80
收:98.86
52周最高:124.00
52周最低:79.52
股本:2.51億
流通股本:1.08億
量比:0.59
換手率:0.55%
股息:- -
股息率:- -
每股收益(TTM):-7.7726
每股收益(LYR):-5.5184
淨資產收益率:-9.30%
總資產收益率:-5.41%
市淨率:1.19
市盈率(LYR):-17.52

資料載入中...

2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 | BioNTech 大股東 ATHOS KG 擬減持55605股,總價約693萬美元
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 10%股東 ATHOS KG 擬減持50萬股,總價約6170萬美元
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 股東 ATHOS KG 擬減持90000股,總價約1134萬美元
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/03/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]